LaBella Nicholas A. Jr.
Insider CIK 1487698 · ZVSA Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 39,708 | — | $0 | 39,708 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 59,563 | — | $0 | 59,563 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 39,709 | — | $0 | 39,709 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 19,854 | — | $0 | 19,854 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 18,094 | — | $0 | 18,094 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 29,781 | — | $0 | 29,781 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2022-12-12 | 2022-12-14 | 29,781 | — | $0 | 29,781 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award | 2022-12-12 | 2022-12-14 | 18,094 | — | $0 | 18,094 | SEC↗ |